J. Toomey

发表

Cytokine requirements for the growth and development of mouse NK cells in vitro

D. Foster, C. Brooks, F. Gays, 2003, Journal of leukocyte biology.

Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver.

A. Georgiou, M. Bennett, M. Manoussaka, 1997, Journal of immunology.

MHC class I expression protects target cells from lysis by Ly49‐deficient fetal NK cells

John H. Robinson, Z. Chrzanowska-Lightowlers, S. A. De La Rue, 1998, European journal of immunology.

Stochastic acquisition of Qa1 receptors during the development of fetal NK cells in vitro accounts in part but not in whole for the ability of these cells to distinguish between class I-sufficient and class I-deficient targets.

Z. Chrzanowska-Lightowlers, P. J. Dyson, J. Lawry, 1999, Journal of immunology.

I-Deficient Targets Between Class I-Sufficient and Class the Ability of These Cells to Distinguish Vitro Accounts in Part But Not in Whole for During the Development of Fetal NK Cells In Stochastic Acquisition of Qa 1 Receptors

John H. Robinson, Z. Chrzanowska-Lightowlers, P. J. Dyson, 1999 .

Fetal mouse NK cell clones are deficient in Ly49 expression, share a common broad lytic specificity, and undergo continuous and extensive diversification in vitro.

M. Manoussaka, C. Brooks, J. Toomey, 1998, Journal of immunology.

Immunogenicity of a Heptavalent Conjugate Pneumococcal Vaccine Administered Concurrently with a Combination Diphtheria, Tetanus, Five-Component Acellular Pertussis, Inactivated Polio, and Haemophilus influenzae Type b Vaccine and a Meningococcal Group C Conjugate Vaccine at 2, 3, and 4 Months of Age

A. Gennery, A. Fenton, R. Borrow, 2009, Clinical and Vaccine Immunology.

Functional Analysis of the Molecular Factors Controlling Qa1-Mediated Protection of Target Cells from NK Lysis1

P. J. Dyson, C. Brooks, A. Diamond, 2001, The Journal of Immunology.

Target Cells from NK Lysis Controlling Qa 1-Mediated Protection of Functional Analysis of the Molecular Factors

P. J. Dyson, C. Brooks, A. Diamond, 2001 .

Responses to a Conjugate Pneumococcal Vaccine in Preterm Infants Immunized at 2, 3, and 4 Months of Age

A. Gennery, A. Fenton, S. Moss, 2010, Clinical and Vaccine Immunology.